Bioethics

  • Read more: Changing human-subjects regulations? Tune in now

    Changing human-subjects regulations? Tune in now

    By Laura Stark Today and tomorrow, the National Academy of Sciences is hosting a workshop on revisions to the human-subjects regulations (the “Common Rule”), especially for rules on social and behavioral research. The workshop is being simulcast, and viewers can send in questions. Join us! The most provocative presentation this morning, from my perch in…

  • Read more: Caplan on Pediatric Anthrax Vaccine Trials

    Caplan on Pediatric Anthrax Vaccine Trials

    By Arthur Caplan Art Caplan has a new column responding to the latest report from the Presidential Commission for the Study of Bioethical Issues.  Take a look: A top-level commission has just released a new report on the morality of studying the safety of an anthrax vaccine in children, with an eye toward treating kids…

  • Read more: Reminder, Upcoming Conference on Universal Health Coverage in Low-Income Countries

    Reminder, Upcoming Conference on Universal Health Coverage in Low-Income Countries

    By The Petrie-Flom Center A reminder that the Harvard University Program in Ethics and Health annual conference, Universal Health Coverage in Low-Income Countries: Ethical Issues, will be held in Boston on April 18-19, 2013. AGENDA https://peh.harvard.edu/events/2013/universal_coverage/agenda.html REGISTRATION No fee. Space limited. Registration required. Please register on our registration website.  

  • Read more: March 28: Jessica Flanigan speaking to the HMS Division of Medical Ethics

    March 28: Jessica Flanigan speaking to the HMS Division of Medical Ethics

    Please join the HMS Division of Medical Ethics for …   “Why patients should have access to all drugs without a prescription” Jessica Flanigan, PhD Assistant Professor of Leadership Studies and Philosophy, Politics, Economics and Law University of Richmond Thursday, March 28, 2013; 4:00 – 5:30 PM HMS Division of Medical Ethics 1st Floor Conference Room…

  • Read more: New Amicus Brief Filed on Behalf of Dr. Eric Lander in the Supreme Court in the Myriad (Gene Patent) Case

    New Amicus Brief Filed on Behalf of Dr. Eric Lander in the Supreme Court in the Myriad (Gene Patent) Case

    By I. Glenn Cohen I am pleased to announce that Gideon Schor, Vern Noviel, and I filed an amicus brief on behalf of Dr. Eric S. Lander in a pending Supreme Court case that will address whether human genes are patentable.  The case is Association for Molecular Pathology v. Myriad Genetics, No. 12-398 and will be argued April 15, 2013.  Lander is a…

  • Read more: Family, Privacy, Secrets, & The Law

    Family, Privacy, Secrets, & The Law

    By Michele Goodwin The Family, Privacy, Secrets, & The Law Roundtable (March 7-8. 2013) was a great success.  Kudos to the brilliant presenters and commentators who came together for this important, groundbreaking session, including Lori Andrews, Glenn Cohen, June Carbone, Laura Rosenbury, Camille Gear Rich, Martha Field, Deborah Epstein, Martha Ertman, Gaia Bernstein, Taunya Banks,…

  • Read more: Caplan on “$10,000 to Abort?”

    Caplan on “$10,000 to Abort?”

    By Arthur Caplan Art Caplan has a new column up discussing the surrogacy agreement gone awry (noted by Judy Daar below) in which a surrogate was offered $10K to abort the fetus upon discovery of abnormalities.  Take a look. We’ve also had other discussions of this issue at Bill of Health, from Dov Fox’s recent…

  • Read more: The ADA and Declining Down Syndrome Birthrates

    The ADA and Declining Down Syndrome Birthrates

    By Dov Fox Having a child is hard work. It can be especially taxing—“physically, emotionally, and of course, financi[]ally, to bring a child with [disabilities] . . . into the world and raise it,” as commentators have noted in response to an earlier version of this piece that Chris Griffin and I wrote yesterday on…

  • Read more: You Talkin’ to Me?

    You Talkin’ to Me?

    By Suzanne M. Rivera, Ph.D. The principle of justice articulated in The Belmont Report requires equitable selection of human research subjects.  Equitable in this context means that the risks and benefits of the study are distributed fairly.  Fairness has two components: 1) avoiding exploitation of the vulnerable (e.g. preying upon a poor, uneducated population) and…